Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD)

NCT00726973 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to recruit study participants

Conditions

Macular Edema

Interventions

DRUG: Ranibizumab
DRUG: Ranibizumab monotherapy

Sponsor

Lahey Clinic